A specialised clinical trials unit of East Kent Hospitals University NHS Foundation Trust has been working closely with patients to identify new ways of treating blood and lymphatic cancers. The Clinical Services Journal reports.
Kent and Canterbury Hospital’s contribution to global research along with patients’ engagement and clinical trial participation has led to international recognition for the unit’s commitment to the development of innovative drugs and treatments in this field.
Lavinia Davey, senior clinical trials coordinator, said: “We’re proud to be at the cutting edge of research that is making a real difference to patients’ lives and also making the most of the resources that we have in the NHS go further.”
While there is clearly a commitment to research in terms of advancing knowledge, for the research team their most important value is to provide the best care to their patients. Clinical trials provide the team the opportunity to access the best treatments available for their patients.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
